Influence of Improved Formula on Fatty Acids and Mineral Metabolism in Infants

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02587702

Enrollment

Registered

2015-10-27

Start date

2013-06-30

Completion date

Unknown

Last updated

2015-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Term Infants

Brief summary

The purpose of this study is to determine whether different content of β-palmitate will cause significant differences on Fatty Acids and Mineral Metabolism in Infants

Interventions

OTHERβ-Palmitate Content

OTHERPlacebo

OTHERβ-Palmitate Content Naturely in Human Milk

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

BASIC_SCIENCE

Masking

DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender

ALL

Age

No minimum to 7 Days

Healthy volunteers

Yes

Inclusion criteria

* Healthy full term infants

Exclusion criteria

* experienced congenital or chromosomal disorders * neonatal morbidities, or metabolic illness

Design outcomes

Primary

Measure	Time frame
Content of fatty acids	3 years
Content of calcium and magnesium	3 years

Secondary

Measure	Time frame	Description
Anthropometric measurements	3 years	Index of anthropometric measurements contains weight,height and head circumference.
Stool characteristics assessed via stool frequency	3 years	—
Stool characteristics assessed via stool consistency	3 years	—

Countries

China

Contacts

Primary ContactFei Bei, Master

Fionabei@163.com86-21-38625778

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026